Recent PHVS News
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 09/23/2024 10:51:03 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 09/20/2024 08:27:56 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 09/19/2024 10:45:56 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 09/19/2024 10:44:09 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 09/19/2024 08:27:35 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 09/16/2024 08:46:52 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 09/05/2024 10:51:14 AM
- Pharvaris Provides Business Update and Expands Development Program for Deucrictibant • GlobeNewswire Inc. • 09/05/2024 10:50:00 AM
- Pharvaris Presents Deucrictibant Long-Term Extension Data for Both the Prophylactic and On-Demand Treatment of HAE at the Bradykinin Symposium 2024 • GlobeNewswire Inc. • 09/05/2024 10:49:00 AM
- Pharvaris Presents Data at the Bradykinin Symposium 2024 • GlobeNewswire Inc. • 09/05/2024 10:48:00 AM
- Deucrictibant Clinical, Real-World, Nonclinical, and Discovery Data to be Presented at the Bradykinin Symposium • GlobeNewswire Inc. • 08/28/2024 10:50:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 08/14/2024 10:51:14 AM
- Pharvaris Reports Second Quarter 2024 Financial Results and Provides Business Update • GlobeNewswire Inc. • 08/14/2024 10:50:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 06/11/2024 10:52:06 AM
- Pharvaris Announces Annual Meeting of Shareholders • GlobeNewswire Inc. • 06/11/2024 10:50:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 06/04/2024 08:05:02 PM
- Pharvaris Highlights Properties of Deucrictibant in Data Presentations at Recent Congresses • GlobeNewswire Inc. • 06/04/2024 10:50:00 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/24/2024 09:04:24 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/22/2024 09:54:50 PM
- Pharvaris to Present Clinical and Nonclinical Data at Upcoming Congresses • GlobeNewswire Inc. • 05/13/2024 10:50:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 05/08/2024 08:11:03 PM
- Pharvaris Reports First Quarter 2024 Financial Results and Provides Business Update • GlobeNewswire Inc. • 05/08/2024 08:10:00 PM
- Pharvaris Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update • GlobeNewswire Inc. • 04/10/2024 08:10:00 PM
- Pharvaris Appoints David Nassif, J.D., as Chief Financial Officer • GlobeNewswire Inc. • 04/10/2024 08:08:00 PM
- Pharvaris to Present Deucrictibant Clinical Data at the CIIC Spring 2024 Conference • GlobeNewswire Inc. • 04/04/2024 10:50:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM